Harvest Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Harvest Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-44,100	Closed	-$9.56M	–	83
2021 Q1	$9.56M	Buy	+44,100	New	+$8.29M	5.73%	4
2018 Q4	–	Sell	-1,200	Closed	-$207K	–	55
2018 Q3	$207K	Buy	+1,200	New	+$173K	0.12%	82
2018 Q2	–	Sell	-2,100	Closed	-$237K	–	124
2018 Q1	$237K	Buy	2,100 +100	+5%	+$12.6K	0.12%	92
2017 Q4	$264K	Buy	+2,000	New	+$235K	0.17%	61

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Harvest Management's GWPH Position: Q2 2021 in Review

Harvest Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 44,100 shares — an estimated $9.56M sold.

Harvest Management first reported a position in GWPH in Q4 2017 and held it in 4 quarters. The position peaked at $9.56M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Harvest Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Harvest Management sold 44,100 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $9.56M.
Harvest Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2017 and held it in 4 quarters.
Harvest Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $9.56M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Harvest Management's 13F filing for Q2 2021, filed 23 Jul 2021.